A child receives a dose of COVID-19 vaccine.


On Friday, sources revealed that the Drugs Controller General of (DCGI) India recommended Emergency Use Authorisation (EUA) for Serum Institute of India’s Covovax vaccine for children aged 7-11.

“The Subject Expert Committee of Drugs Controller General Of India has recommended Serum Institute of India’s (SII) vaccine Covovax for children in the age group of 7-11 years,” said the source.

The expert panel recommendation has been sent to the DCGI for final approval.

However, DGCI will review the recommendation before nodding for final approval. In its last meeting in April, the expert panel sought more information from Serum Institute over the application, as per the source.

India’s drug regulator had approved Covovax for restricted use in emergencies in adults on December 28, 2021, and in the 12-17 age group with certain conditions on March 9.


The above article has been published from a wire agency with minimal modifications to the headline and text.